WORLDMaine poll shows Collins leads Jackson by 3 pointsOct 1, 2026
WORLDFDA nominee Heidi Overton declines to call healthcare a human rightOct 1, 2026
WORLDFox News outdraws CNN and MS NOW combined in Q3 2026Sep 30, 2026
RVPRetractable Technologies declares quarterly preferred dividendsSep 30, 2026
$BTCBitcoin ETFs Hold 6.29% of Supply, Targeting 10% by Mid-2029Sep 30, 2026
SLXNSilexion doses first patient in Phase 2/3 pancreatic cancer trialSep 30, 2026
REGULATORYAtlassian CEO Mike Cannon-Brookes rejects SaaSpocalypse narrativeSep 30, 2026
$BTCAnalyst ranks Bitcoin above Dogecoin as superior crypto buySep 30, 2026
WORLDMaine poll shows Collins leads Jackson by 3 pointsOct 1, 2026
WORLDFDA nominee Heidi Overton declines to call healthcare a human rightOct 1, 2026
WORLDFox News outdraws CNN and MS NOW combined in Q3 2026Sep 30, 2026
RVPRetractable Technologies declares quarterly preferred dividendsSep 30, 2026
$BTCBitcoin ETFs Hold 6.29% of Supply, Targeting 10% by Mid-2029Sep 30, 2026
SLXNSilexion doses first patient in Phase 2/3 pancreatic cancer trialSep 30, 2026
REGULATORYAtlassian CEO Mike Cannon-Brookes rejects SaaSpocalypse narrativeSep 30, 2026
$BTCAnalyst ranks Bitcoin above Dogecoin as superior crypto buySep 30, 2026

Arsenal Capital Partners Adds Max Schechter as Managing Director and Head of Industrial Growth Business Development

Arsenal Capital Partners, a New York-based middle-market private equity firm specializing in industrial growth and healthcare companies, has appointed Max Schechter as Managing Director and Head of Business Development for its industrial…

By Warren Ashby·Jun 21, 2026·1 min read·markets

Key takeaways

  • Arsenal Capital Partners appointed Max Schechter as Managing Director and Head of Business Development for its industrial growth business, announced June 18, 2026.
  • Arsenal Capital Partners is a New York-based middle-market private equity firm specializing in industrial growth and healthcare companies.
  • Schechter's role focuses on origination and strategy for Arsenal's industrial growth vertical, anchoring deal flow, intermediary relationships, and sector outreach.
  • Arsenal did not disclose Schechter's prior positions, specific targets, financial terms, fund sizes, or portfolio specifics.
  • The hire signals Arsenal is prioritizing systematic, proprietary deal origination within its industrial vertical rather than relying solely on inbound intermediary flow.

Arsenal Capital Partners, a New York-based middle-market private equity firm specializing in industrial growth and healthcare companies, has appointed Max Schechter as Managing Director and Head of Business Development for its industrial growth business. The firm announced the hire on June 18, 2026.

Schechter's Role at Arsenal

Schechter's mandate sits at the intersection of origination and strategy for Arsenal's industrial growth vertical. The business development function at a middle-market PE firm of Arsenal's profile typically anchors deal flow, intermediary relationships, and sector outreach — responsibilities that become increasingly consequential as competition for quality industrial assets intensifies. Arsenal did not disclose prior positions held by Schechter or specific targets tied to the appointment.

Arsenal's Dual-Platform Focus

Arsenal Capital Partners operates across two defined verticals: industrial growth and healthcare. The firm positions itself as a builder of companies within those sectors, a characterization that signals an operational emphasis rather than a purely financial-engineering approach. The industrial growth platform, which Schechter's new role directly supports, pursues middle-market businesses — a segment generally defined by enterprise values that fall below the threshold attracting the largest buyout funds, and one where sourcing relationships and sector-specific expertise carry outsized weight.

The addition of a dedicated business development head at the Managing Director level suggests Arsenal is prioritizing systematic deal origination within its industrial vertical rather than relying solely on inbound intermediary flow.

Positioning Signal

Naming a senior business development executive to a named vertical is a tactical move common among middle-market firms looking to differentiate on proprietary sourcing. For Arsenal, the industrial growth platform now has dedicated leadership on the origination side, aligning with the firm's stated specialization in building companies rather than harvesting them.


Source details are limited to the firm's announcement as released via PRNewswire on June 18, 2026. No financial terms, fund sizes, or portfolio specifics were disclosed in the source.

Share
© 2026 NewsMeter

Frequently asked

Who is Max Schechter and what is his new role?

Max Schechter was appointed Managing Director and Head of Business Development for Arsenal Capital Partners' industrial growth business, focusing on origination and strategy for that vertical.

When was the appointment announced?

Arsenal Capital Partners announced the hire on June 18, 2026, via a PRNewswire release.

What does Arsenal Capital Partners specialize in?

Arsenal is a New York-based middle-market private equity firm operating across two verticals: industrial growth and healthcare, positioning itself as a builder of companies in those sectors.

What does the business development head role involve?

The role anchors deal flow, intermediary relationships, and sector outreach, supporting systematic deal origination for Arsenal's industrial growth platform.

Were any financial details disclosed?

No financial terms, fund sizes, or portfolio specifics were disclosed, and Arsenal did not reveal Schechter's prior positions or specific targets tied to the appointment.